J. H. Beijnen

1.0k total citations
40 papers, 797 citations indexed

About

J. H. Beijnen is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, J. H. Beijnen has authored 40 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Oncology and 6 papers in Infectious Diseases. Recurrent topics in J. H. Beijnen's work include HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). J. H. Beijnen is often cited by papers focused on HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). J. H. Beijnen collaborates with scholars based in Netherlands, United States and Spain. J. H. Beijnen's co-authors include A. Bult, W.J.M. Underberg, Jan H.M. Schellens, Cornelis A. Hoefnagel, Hilde Rosing, Léon Reubsaet, Henk Boot, B.G. Taal, R.A. Valdés Olmos and R. A. A. Maes and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

J. H. Beijnen

40 papers receiving 761 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. H. Beijnen Netherlands 17 320 295 133 100 96 40 797
Banmeet S. Anand United States 20 344 1.1× 386 1.3× 163 1.2× 103 1.0× 12 0.1× 38 1.0k
Qi Tan China 17 396 1.2× 128 0.4× 104 0.8× 87 0.9× 25 0.3× 44 817
Jacintha Shenton United States 13 253 0.8× 153 0.5× 54 0.4× 73 0.7× 10 0.1× 18 753
James W. Darnowski United States 17 722 2.3× 358 1.2× 93 0.7× 145 1.4× 16 0.2× 31 1.1k
Yoshio Kodera Japan 16 448 1.4× 102 0.3× 56 0.4× 22 0.2× 52 0.5× 33 768
Arlene R. Cashmore United States 22 721 2.3× 243 0.8× 85 0.6× 111 1.1× 16 0.2× 35 1.3k
Zsolt Holló Hungary 15 583 1.8× 1.1k 3.8× 77 0.6× 221 2.2× 9 0.1× 20 1.5k
Bing Lu China 16 382 1.2× 201 0.7× 73 0.5× 95 0.9× 6 0.1× 34 771
Alec W. Gough United States 16 181 0.6× 92 0.3× 69 0.5× 23 0.2× 25 0.3× 32 697

Countries citing papers authored by J. H. Beijnen

Since Specialization
Citations

This map shows the geographic impact of J. H. Beijnen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. H. Beijnen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. H. Beijnen more than expected).

Fields of papers citing papers by J. H. Beijnen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. H. Beijnen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. H. Beijnen. The network helps show where J. H. Beijnen may publish in the future.

Co-authorship network of co-authors of J. H. Beijnen

This figure shows the co-authorship network connecting the top 25 collaborators of J. H. Beijnen. A scholar is included among the top collaborators of J. H. Beijnen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. H. Beijnen. J. H. Beijnen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vries, Niels de, et al.. (2025). Clinical Application of Volumetric Absorptive Microsampling for Therapeutic Drug Monitoring of Oral Targeted Anticancer Drugs. Therapeutic Drug Monitoring. 47(5). 625–634. 3 indexed citations
2.
Noort, Vincent van der, et al.. (2025). The feasibility of using real world data as external control arms in oncology trials. Drug Discovery Today. 30(3). 104324–104324. 1 indexed citations
3.
4.
Henricks, Linda M., Frans L. Opdam, J. H. Beijnen, Annemieke Cats, & Jan H.M. Schellens. (2017). DPYD genotype-guided dose individualization to improve patient safety of fluoropyrimidine therapy: call for a drug label update. Annals of Oncology. 28(12). 2915–2922. 60 indexed citations
5.
Jager, Nynke G L, Hilde Rosing, Jan H.M. Schellens, J. H. Beijnen, & SC Linn. (2014). Use of dried blood spots for the determination of serum concentrations of tamoxifen and endoxifen. Breast Cancer Research and Treatment. 146(1). 137–144. 28 indexed citations
6.
Lankheet, Nienke A. G., Christian U. Blank, Henk Mallo, et al.. (2011). Determination of Sunitinib and Its Active Metabolite N-Desethylsunitinib in Sweat of a Patient. Journal of Analytical Toxicology. 35(8). 558–565. 30 indexed citations
7.
Oostendorp, Roos L., et al.. (2007). Phase I and pharmacological study of orally administered indibulin in advanced solid tumors. Journal of Clinical Oncology. 25(18_suppl). 2565–2565. 1 indexed citations
8.
Campone, M., Jeany M. Rademaker-Lakhai, Jaafar Bennouna, et al.. (2004). 606 Phase I and pharmacological study of AP5346, an HPMA copolymer-linked DACH platinum therapeutic, in patients with solid progressive tumors. European Journal of Cancer Supplements. 2(8). 183–183. 2 indexed citations
9.
Waterval, Joop C. M., Rolf W. Sparidans, J. H. Beijnen, et al.. (2001). Degradation kinetics of aplidine, a new marine antitumoural cyclic peptide, in aqueous solution. Journal of Chromatography B Biomedical Sciences and Applications. 754(1). 161–168. 6 indexed citations
10.
Nuijen, Bastiaan, Marjan Bouma, José Jimeno, et al.. (2000). Pharmaceutical development of anticancer agents derived from marine sources. Anti-Cancer Drugs. 11(10). 793–811. 52 indexed citations
11.
Beijnen, J. H., et al.. (2000). Degradation of Azaglycinamido Residues in Model Tripeptides Derived from Goserelin. Journal of Pharmaceutical Sciences. 89(1). 108–114. 1 indexed citations
12.
Veldkamp, Agnes I., Rolf W. Sparidans, Richard M. W. Hoetelmans, & J. H. Beijnen. (1999). Quantitative determination of abacavir (1592U89), a novel nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection. Journal of Chromatography B Biomedical Sciences and Applications. 736(1-2). 123–128. 21 indexed citations
13.
Veldkamp, Agnes I., Rolf P. G. van Heeswijk, Richard M. W. Hoetelmans, et al.. (1999). Rapid quantification of delavirdine, a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with fluorescence detection. Journal of Chromatography B Biomedical Sciences and Applications. 727(1-2). 151–157. 7 indexed citations
14.
Sparidans, Rolf W., Agnes I. Veldkamp, Richard M. W. Hoetelmans, & J. H. Beijnen. (1999). Improved and simplified liquid chromatographic assay for adefovir, a novel antiviral drug, in human plasma using derivatization with chloroacetaldehyde. Journal of Chromatography B Biomedical Sciences and Applications. 736(1-2). 115–121. 16 indexed citations
15.
León, José de, Léon Reubsaet, J. H. Beijnen, et al.. (1999). Reduction of Cys36–Cys42 and Cys64–Cys74 disulfide bonds in recombinant human granulocyte colony stimulating factor. Journal of Pharmaceutical and Biomedical Analysis. 19(6). 837–845. 7 indexed citations
16.
Taal, B.G., Cornelis A. Hoefnagel, R.A. Valdés Olmos, Henk Boot, & J. H. Beijnen. (1996). Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors.. Journal of Clinical Oncology. 14(6). 1829–1838. 87 indexed citations
17.
Warmerdam, L.J.C. van, Jaap Verweij, Jan H.M. Schellens, et al.. (1995). Pharmacokinetics and pharmacodynamics of topotecan administered daily for 5 days every 3 weeks. Cancer Chemotherapy and Pharmacology. 35(3). 237–245. 84 indexed citations
18.
Burger, David M., et al.. (1995). Study on didanosine concentrations in cerebrospinal fluid. Pharmacy World & Science. 17(6). 218–221. 28 indexed citations
19.
Burger, David M., Chris H.H. ten Napel, Jan W. Mulder, et al.. (1994). Pharmacokinetic variability of zidovudine in HIV-infected individuals. AIDS. 8(12). 1683–1690. 37 indexed citations
20.
Kroon, B.B.R., et al.. (1994). Melphalan tissue concentrations in patients treated with regional isolated perfusion for melanoma of the lower limb. British Journal of Cancer. 70(1). 151–153. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Banmeet S. Anand Breakdown of academic impact, for papers by Qi Tan Breakdown of academic impact, for papers by Jacintha Shenton Breakdown of academic impact, for papers by James W. Darnowski Breakdown of academic impact, for papers by Yoshio Kodera Breakdown of academic impact, for papers by Arlene R. Cashmore Breakdown of academic impact, for papers by Zsolt Holló Breakdown of academic impact, for papers by Bing Lu Breakdown of academic impact, for papers by Alec W. Gough
Rankless by CCL
2026